Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Endometrial Hyperplasia 2 Turcot syndrome 1 Overweight 1 Obesity 1 Neoplasms 1 Carcinoma, Endometrioid 1 Breast Neoplasms 1 Breast Cancer Patients Treated With T-DXd 1

Interventions

Trastuzumab 16 pertuzumab 14 Capecitabine 14 Docetaxel 12 pyrotinib 11 Cyclophosphamide 11 Standard of Care 10 Paclitaxel 10 Letrozole 10 trastuzumab deruxtecan 9 Radiotherapy 9 Carboplatin 9 Fulvestrant 8 Drug Therapy 8 sacituzumab govitecan 7 dalpiciclib 7 exemestane 6 eribulin 6 Tamoxifen 6 Epirubicin 6 Anastrozole 6 pembrolizumab 5 palbociclib 5 abemaciclib 5 Surveys and Questionnaires 5 Neoadjuvant Therapy 5 Aromatase Inhibitors 5 camrelizumab 4 Sentinel Lymph Node Biopsy 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Megestrol Acetate × Clear all

NCT07543536 2026-04-22

MEGA-TACT-BC3

Sun Yat-sen University

Phase 3 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡